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Off-target or random integration of exogenous DNA hampers precise genomic engineering
and presents a safety risk in clinical gene therapy strategies. Genetic deﬁnition of random
integration has been lacking for decades. Here, we show that the A-family DNA polymerase θ
(Pol θ) promotes random integration, while canonical non-homologous DNA end joining
plays a secondary role; cells double deﬁcient for polymerase θ and canonical non-
homologous DNA end joining are devoid of any integration events, demonstrating that these
two mechanisms deﬁne random integration. In contrast, homologous recombination is not
reduced in these cells and gene targeting is improved to 100% efﬁciency. Such complete
reversal of integration outcome, from predominately random integration to exclusively gene
targeting, provides a rational way forward to improve the efﬁcacy and safety of DNA delivery
and gene correction approaches.
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Gene targeting, the precise engineering of genomes throughthe homologous integration of exogenous DNA, is ham-pered by the orders of magnitude higher efﬁciency of
untargeted random integration (RI)1. RI does not rely on
sequence homology, happens with no or little detectable sequence
preference, results in insertional mutations, and is hence often
referred to as “illegitimate recombination”. The mechanism of RI
in higher eukaryotes has been enigmatic for decades, because it
has evaded rigorous genetic deﬁnition. Integration of exogenous
DNA at unpredictable positions in the genome can heavily
impact on the functioning of the integrated DNA, as well as its
genomic environment, and thus presents a safety risk2–4. With
the advent of CRISPR-Cas9 technology and its seemingly inevi-
table implementation in clinically relevant gene-correction stra-
tegies5, it becomes all the more important to devise strategies to
counteract the potentially detrimental outcomes of RI. Efforts to
shift the RI/HR balance of exogenous DNA integration towards
HR have been only marginally successful6, 7. One reason is the
lack of mechanistic understanding of RI relative to HR. From the
analysis of integration sites the involvement of DNA topoi-
somerases has been suggested but not proven8, 9. Because a
double-stranded break (DSB) in the chromosome is ultimately
required to ligate the incoming DNA, and because DSB induction
stimulates RI10–13, it has been hypothesized that homology-
independent DSB end joining (EJ) proteins are involved. In
mammalian cells EJ activity is primarily mediated by the C-NHEJ
pathway involving Ku70-Ku80, DNA-PKcs, and the
LigIV–XRCC4 complex14. Strikingly in mouse embryonic stem
(ES) cells, where Ku proteins are not essential, complete inacti-
vation of C-NHEJ does not result in any increase in gene tar-
geting15, 16. A possible explanation is the existence of alternative
pathways for EJ. Indeed, when C-NHEJ is suppressed some
residual EJ activity remains. This so-called alternative EJ (Alt-EJ)
is genetically not well deﬁned, and may be an umbrella term for
several distinct auxiliary or context-speciﬁc EJ activities. Because
the DNA junctions resulting from EJ activities in C-NHEJ
impaired cells are characterized by minute stretches of sequence
homology, also the term micro-homology-mediated end joining
has been used. Proteins implicated in potentially different alter-
native EJ activities include PARP116, 17, Pol θ18, CtIP19, 20, the
MRN21 complex, LigI and LigIII22, 23.
Here we show that the A-family DNA polymerase θ (Pol θ)
promotes most of RI events. In the absence of Pol θ, the major
DNA double-strand break (DSB) repair pathway, canonical non-
homologous DNA end joining (C-NHEJ), mediates residual RI.
We detected not a single RI event in cells lacking both Pol θ and
C-NHEJ, indicating that if additional pathways of RI exist, their
contribution is at least four orders of magnitude lower. Strikingly,
we ﬁnd that the characteristic unfavorable balance between
homologously targeted DNA integration and RI in mammalian
cells is completely reversed in cells defective for Pol θ and C-
NHEJ.
Results
Pol θ and C-NHEJ inactivation prevents random integration.
We used CRISPR-Cas9 to inactivate Polq, the gene encoding Pol
θ, and key C-NHEJ genes Ku70, Ku80 and LigIV, and a combi-
nation of Polq Ku70 and Polq Ku80 in mouse ES cells (Fig. 1a,
Supplementary Figs. 1 and 2); two independent knock-out cell
lines were generated for each genotype. The observation that
single-mutant cells were hypersensitive toward IR validated
functional impairment of the encoded proteins. Strikingly, double
mutant cells displayed a synergistic increase in IR sensitivity
arguing for redundant activities of C-NHEJ and Pol θ on
radiation-induced DNA damage (Supplementary Fig. 2). Next, we
measured the ability of these knockout cells to form stable
puromycin-resistant colonies upon RI of transfected plasmid
DNA encoding a puromycin resistance gene (Fig. 1a, b). Con-
ﬁrming previous work15, 16, the frequency of transfected DNA
integration was unaffected by C-NHEJ inactivation, however, we
found it to be severely reduced in Polq–/– cells (11% of wild-type).
Deﬁciency in nuclear form of the Alt-EJ protein LigIII22–24 did
not result in RI frequency decrease (Supplementary Fig. 3), which
may be due to redundancy of LigIII and LigI as was previously
observed in manifestations of Alt-EJ22, 23. Our observation that
loss of C-NHEJ does not at all affect RI slightly deviates from an
earlier study reporting a modest decrease in RI upon LIG4
depletion25, which could be explained by different cell- or growth
characteristics for mouse ES cells versus transformed human
somatic cells that could affect usage of EJ pathways: mouse ES
cells are primarily in S-phase and are thus perhaps more geared
up to repair breaks via HR or alt-EJ. We conclude that RI in
mouse ES cells is predominantly resulting from Pol θ-mediated
repair and refer to this process as TMEJ (for polymerase Theta-
Mediated EJ) to distinguish it from C-NHEJ and to acknowledge
the notion that Alt-EJ may also encompass Pol θ-independent
repair.
This conclusion is supported by the observation that integra-
tion sites in Pol θ proﬁcient cells, but not in Polq–/– cells,
frequently resulted in junctions that contained small insertions,
which are suggestive of template-based polymerase action primed
by the local presence of homologous sequences (Fig. 2 and
Supplementary Data 1, 2). Noteworthy, the observed inserts had a
striking similarity with those identiﬁed at the junctions of
translocations that give rise to Ewing Sarcoma26. The occasional
presence of templated insertions is a signature feature of Pol θ-
mediated repair of DSBs27, 28.
Simultaneous inactivation of Pol θ and Ku70, Ku80 or LigIV
resulted in a complete inability of cells to integrate transfected
DNA (Fig. 1b). We did not recover a single puromycin-resistant
colony in multiple experiments involving more than 1.5×108
Polq–/– Ku70–/–, 7.5×107 Polq–/– Ku80–/– and 2.4×108 Polq–/–
Lig4–/– cells. No signiﬁcant differences in transient transfection
efﬁciency, as measured by expression of ﬂuorescent marker 1 day
after transfection, was observed between the genotypes (Supple-
mentary Fig. 2b). We conclude that the residual level of RI in
Polq–/– cells results from C-NHEJ.
We conﬁrmed that total suppression of RI in Polq–/– Ku70–/–
cells was due to loss of Pol θ by complementing Polq–/– Ku70–/–
cells with a gene encoding Flag-tagged human Pol θ (Fig. 1c). The
wild-type form of human Pol θ restored RI capacity, while mutant
versions of the protein with abrogated ATPase or polymerase
activity did not.
Pol θ inactivation facilitates gene targeting. To test whether the
absence of Pol θ affected the balance between RI and HR-
mediated targeted integration we used our previously established
Rad54-GFP gene targeting assay29, which measures the ratio
between random (GFP negative cells) and targeted integration
(GFP positive cells) of the construct targeting exon 4 of the Rad54
locus using FACS (Fig. 3a, b). In Polq–/– cells we observed a
profound shift in the shape of the FACS proﬁle from RI peak
towards HR peak. Strikingly, in Polq–/– Ku70–/– cells only HR-
mediated gene targeting events were detected. The changes in the
FACS proﬁles were associated with a reduction in the total
number of integrants (puromycin-resistant cells regardless of
GFP status). These results are consistent with a reduction in the
efﬁciency of RI in Polq–/– and complete inactivation of RI in
Polq–/– Ku70–/– cells. This outcome also proves that the observed
reduction in RI is not resulting from diminished delivery or
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stability of transfected DNA30. Since induction of DSBs stimu-
lates RI, we next tested whether γ-irradiation affected the HR/RI
ratio. Indeed, we observed signiﬁcant stimulation of RI in wild-
type and single mutant cells (Fig. 3b). However, even under these
stimulatory conditions, no RI was detected in Polq–/– Ku70–/–
cells, and only HR manifested. As most gene targeting strategies
currently involve stimulation by DSB induction at the target
locus, we tested whether loss of Pol θ and C-NHEJ is also ben-
eﬁcial in the context of CRISPR-Cas9-stimulated gene targeting,
and indeed it is (Supplementary Fig. 4).
HR-mediated gene targeting at exon 4 of Rad54 is very
efﬁcient: 30–70% compared to ~5% for an average location in
mouse ES cells. Therefore, we tested whether the high gene
targeting efﬁciency we observed in Polq–/– cells will be maintained
in a more typical scenario. Constructs that target exon 9 or 18 of
Rad54 (Fig. 3a) recombine with much lower frequency (<5% in
wild type cells, which results in a GFP-positive cell frequency
below detection threshold). For these constructs, we also found a
profound shift from RI towards HR in Polq–/– cells (Fig. 3d). This
phenomenon is not speciﬁc for the Rad54 locus, as we detected a
three-fold increase in relative gene targeting efﬁciency (ratio
between random and targeted integration frequencies, resulting in
puroR+hygroR– and puroR+hygroR+phenotypes, respectively) at
another genomic locus, i.e., the Pim1 gene (Fig. 3c). We conclude
that Pol θ inhibition is a useful method to dramatically and
generally increase gene targeting efﬁciency.
Pol θ inactivation does not affect homologous recombination.
Recent studies suggest that Pol θ inhibits HR by interacting with
Rad51 recombinase18, 31. The strong reduction in RI we observed
in Polq–/– cells can account for the increase in the HR/RI ratio
measured in the Rad54-GFP gene targeting assay, however an
increase in HR efﬁciency may also contribute. We used a direct-
repeat GFP (DR-GFP) assay32 to measure DSB-induced gene
conversion and found no effect from genetically inactivating Pol θ
alone (Fig. 4a). In addition, we found no signiﬁcant difference in
the absolute frequency of targeted integration of the Pim1 tar-
geting construct in Pol θ proﬁcient and deﬁcient mouse ES cells
(p= 0.37, n= 4). However, in the DR-GFP assay, the simulta-
neous inactivation of Pol θ and Ku80 resulted in a higher yield of
gene conversion events (Fig. 4a). Thus, a potential increase in HR
through the lack of Pol θ is unlikely to contribute to the increased
gene targeting efﬁciency in Polq–/– mouse ES cells, but may be a
factor when both C-NHEJ and TMEJ are inactive, as these end
joining factors may locally act redundantly to suppress HR.
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Fig. 1 RI is reduced in Polq−/− and completely abrogated in Polq−/− Ku70−/−, Polq−/− Ku80−/− and Polq−/− LigIV−/− cells. a Immuno-blots conﬁrming the
absence of Ku70, Ku80, and LigIV from wild type and Polq−/− ES cells. bMouse ES cells of indicated genotypes were electroporated with linearized plasmid
DNA encoding a puromycin resistance gene and a GFP expression plasmid to measure transfection efﬁciency. Colony counts were adjusted for transfection
and plating efﬁciency. Means and s.e.m. are plotted. c Polq−/− and wild-type control cells complemented with wild-type and mutant versions of the human
POLQ cDNA were transfected with a plasmid encoding a puromycin-resistance gene. After 10 days of puromycin selection CBB-stained plates were
photographed. Right-hand panel shows immuno-blots of Pol θ levels in the clones used in the left-hand panel. Arrowhead indicates full-length Flag-Pol θ
protein, asterisk indicates non-speciﬁc signal
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00124-3 ARTICLE
NATURE COMMUNICATIONS |8:  66 |DOI: 10.1038/s41467-017-00124-3 |www.nature.com/naturecommunications 3
Pharmacological manipulation to improve gene targeting. Our
results described above imply that transient inactivation of RI by
small molecule inhibition of TMEJ and C-NHEJ could obviate the
need for DSB induction (and thereby avoid its associated side
effects) for precise gene targeting in certain genomic engineering
scenarios. We tested whether suppressing residual RI activity in
Polq–/– cells by NU-7441, a compound implicated in C-NHEJ
inhibition by targeting DNA-PKcs activity, increases gene tar-
geting efﬁciency at Rad54 exons 9 and 18 (Fig. 4b). Indeed,
treatment for 24 h after transfection with 10 µM of NU-7441
resulted in a signiﬁcant increase in the ratio of HR to RI in Polq–/–
but not wild-type cells. Thus, our results revealed the essential
targets, Pol θ and C-NHEJ, and demonstrate that pharmacolo-
gical manipulation can provide an opportunity to enhance the
efﬁciency of precise genomic engineering.
Discussion
We established the up until now elusive genetic dependencies of
RI in mammalian cells. We demonstrate that exactly two genome
maintenance pathways, TMEJ and C-NHEJ, carry out all
detectable RI, with TMEJ being the default dominant pathway.
Similar observations have now been made in human cells33. It has
been known for four decades that transforming cells with exo-
genous DNA leads to integration at unpredictable positions in the
genome34, 35, which hampers clinically relevant gene-correction
strategies. The genetic deﬁnition of the major promoters of RI of
exogenous DNA presented here allows the rational design of
methods to improve the efﬁcacy and safety of gene correction
approaches for industrial or medical purposes.
Methods
Cell lines. Mouse ES cells were routinely cultured on gelatinized (0.1% gelatin in
water) dishes in media comprising 1:1 mixture of DMEM (Lonza BioWhittaker
Cat. BE12-604F/U1, with Ultraglutamine 1, 4.5 g/l Glucose) and BRL-conditioned
DMEM, supplemented with 1000 U/ml leukemia inhibitory factor, 10% FCS, 1×
NEAA, 200 U/ml penicillin, 200 µg/ml streptomycin, 89 µM β-mercaptoethanol.
The parental wild-type line (IB10) was a speciﬁc pathogen free clonal isolate of the
129/Ola E14 line36.
For the generation of Polq, Ku80 (Xrcc5), and LigIV knockout cell-lines, ES cells
were cultured on gelatin-coated plates containing irradiated primary mouse
embryonic ﬁbroblasts in knockout Dulbecco’s Modiﬁed Eagle Medium (Gibco)
supplemented with 100 U/ml penicillin, 100 µg/ml streptomycin, 2 mM
GlutaMAX, 1 mM sodium pyruvate, 1× non-essential amino acids, 100 µM β-
mercaptoethanol (all from Gibco), 10% FCS and 1000 U/ml leukemia inhibitory
factor. IB10 cells were transfected with plasmids expressing Cas9-WT-2A-GFP
(pX458 and sgRNAs targeting different sequences in the three genes using
Lipofectamine 2000 (Invitrogen)). Cells were seeded at low density and maintained
with regular medium changes for 8–10 days until colonies were formed. Colonies
were picked and grown in 96-wells format, at (semi) conﬂuence cells were split to
two 96-wells plates. One plate was used for sub-culturing of cells; the other plate
was used for DNA isolation and PCR analysis of the individual clones. Restriction
fragment length polymorphism (RFLP, based on the loss of a unique restriction
site) of PCR-products was used to identify clones with a bi-allelic mutation. PCR-
products of clones that showed bi-allelic mutation were sent for sequencing to
conﬁrm the introduction of a premature stop-codon due to deletions/insertions
that cause a frameshift (Supplementary Fig. 1b). Polq Ku80 double knockout cell
lines were generated by targeting the Polq gene in the resulting Ku80 deﬁcient cell
lines. Experiments described in this study have been done using at least two
independent clonally derived knockout lines per gene. An overview of the targeted
sequences and the oligonucleotides and restriction sites used for the RFLP analysis
can be found in Supplementary Data 3.
Ku70 (Xrcc6) knockout ES cells were generated by CRISPR-Cas9 stimulated
gene targeting with a homologous template. The sgRNA recognizing the sequence
in exon 4 of Ku70 was cloned into pX459 vector37. The information on
oligonucleotides and constructs is provided in Supplementary Data 3 and 4. The
donor template was produced by PCR-ampliﬁcation of two homology arms from
IB10 genomic DNA (3.3 and 2.3-kb long), the PGK-hygro selection cassette and
the high-copy plasmid backbone pBluescript, and ligated using the Gibson
isothermal assembly method38. The construct was partially sequenced to verify the
junctions between the selection cassette and homology arms. Oligonucleotides used
in cloning and genotyping are listed in Supplementary Data 3 and 4. Homologous
template and sgRNA+Cas9 expression constructs were co-electroporated into
1–2×107 IB10 or Polq–/– cells. Selection with 200 µg/ml Hygromycin B (Roche) was
started 1 day after electroporation and maintained with regular media changes for
8–10 days until colonies formed. Colonies were picked using a sterile pipette tip
under the microscope, dispersed with Trypsin-EDTA, divided for re-plating and
for lysis (50 mM KCl, 10 mM Tris–HCl pH 9, 0.1% Triton-X100, 0.15 mg/ml
proteinase K, 60 °C 1 h, 95 °C 15 min) followed by genotyping PCR with K70-e34-
scrF, K70-e34-scrR and PGK-R1 primers. The absence of the band expected form
the wild-type allele was interpreted as an indication of the bi-allelic modiﬁcation of
the locus (~50% clones). A subset of them was expanded, re-genotyped and tested
by immuno-blotting.
Immuno-blotting. Whole cell lysates were fractionated by Tris-glycine SDS–PAGE,
transferred to nitrocellulose membrane and blotted (5% milk, 0.05% Tween 20
PBS, 4 °C overnight) with the following antibodies: Ku70 (C-19 goat polyclonal,
1:2500, Santa Cruz sc-1486), Ku80 (M-20, 1:2000 Santa Cruz sc-1485), LigIV
(1:2000 Abcam ab80514), Flag tag (M2 mAb, 1:5000, Sigma), PARP-1 (C2-10
mAb, 1:5000, ENZO). Uncropped scans of the immuno-blots are show in Sup-
plementary Fig. 5.
Clonogenic survivals. Cells were plated in triplicates in 6-well plates at 100–4000
per well and irradiated using 137Cs (Ku70) or YXlon X-ray generator (Ku80)
immediately after seeding. Colonies were allowed to form for 7 days, after which
cells were ﬁxed and stained.
DNA constructs. pLPL was derived from the construct loxP-PGK-gb2-neo-polyA-
loxP cassette in pGEM-T Easy (a gift from Francis Stewart39) by replacing neo-
mycin phosphotransferase with puromycin N-acetyltransferase CDS. Gene tar-
geting constructs for Rad54 exons 9 and 18 were produced by recombineering with
mobile agents39 with a cassette containing PCR-ampliﬁed fragment of the pre-
viously described exon 4 gene targeting vector,40 encoding part of the RAD54 CDS
downstream of the targeted exons, GFP CDS and PGK polyadenylation signal, and
the loxP-ﬂanged PGK-EM7-neo dual selection cassette into a BAC bMQ-422M23
Sanger 129/Sv BAC library41. Fragments of the modiﬁed BAC were subcloned into
high-copy pBluescript vector using recombineering (retrieval). Plasmids SpCas9
(BB)-2A-GFP (PX458) and SpCas9(BB)-2A-puro (PX459 v2.0) were a gift from
Feng Zhang (Addgene plasmid #48138, #62988). A plasmid based on the
pENTR233 vector and encoding human Pol θ was purchased from the ORFeome
collaboration collection (Dharmacon), and re-cloned into pAZ125 PiggyBac vector,
GCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATA
GCTGTTTCCTGTGTGAAATTGTgagcggataACTGAGTCTGGGCTATAG
TGGTCCTTGGATTTTAGGGCCCTGCTCTGAGACTGAGTCTGGGCTATAG
Foreign
Genome
Junction
Foreign
Genome
Junction
AACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCG
AACTCACATTAATTGCGTTGCGggcagCTCAGCTTGGGCTTCTGAAATA
CTCCACTCTTGGACCACACCCCCAACCCTCAGCTTGGGCTTCTGAAATA
No insertion
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Fig. 2 Different junctional diversity at RI sites in wild-type and Polq−/− cells. a Schematic representation of junctions found at RI sites: (i) simple deletions
that are without insertions (in grey), (ii) complex junctions that contain insertions, which display sequence identity to the transfected DNA but in a reverse
complement (RC) orientation (in red), and (iii) complex junctions with untraceable miscellaneous insertions (in pink); *** denotes p< 0.001 in Fischer’s
exact test. b Two representative cases of insertion-containing transfected DNA-genome junctions. Junctional sequences that are identical to the
transfected (foreign) DNA (in bold) or the mouse genome are marked. Micro-homologous sequences are boxed. Identical sequences in a RC orientation are
underlined
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which was derived from 5′-PTK-3′42 by replacing the transposon cargo (XhoI-SpeI
fragment) with two expression cassettes: loxP-ﬂanked PGK→neo and CAG→[ClaI
XhoI]~bGHpa (bovine growth hormone polyadenylation signal). BglII-KasI frag-
ment of Pol θ CDS and two PCR-ampliﬁed fragments covering parts of Pol θ CDS
not included in the BglII-KasI fragment were inserted into pAZ125 using Gibson
assembly38. Point mutations to produce D216A, E217A (ATPase-deﬁcient),
T2239S, G2240R, R2241K (polymerase-deﬁcient), and the double ATPase+poly-
merase deﬁcient forms of Pol θ were introduced by PCR ampliﬁcation with Q5
polymerase (NEB) of the POLQ CDS fragments, and insertion into pAZ125 using
Gibson assembly. Two sgRNAs targeting the Rad54 exon 18 region between the
homology arms of the corresponding targeting construct, and thus replaced by the
GFP-PKG-neo cassette upon recombination, were cloned in pX459.
Gene targeting assays. For Rad54 gene targeting assay 107 were electroporated
with 10 µg PvuI-linearized gene targeting construct and plated in 10 gelatinized 10
cm dishes. For experiments involving irradiation, cells were seeded in duplicate,
one of which irradiated with 200 mGy using 137Cs source. The following day
media was exchanged to selective media (1.5 µg/ml puromycin for exon 4
constructs, 500 µg/ml G418 for exon 9 and 18 constructs). Where indicated,
sgRNA+Cas9 expression construct was co-transfected with the gene targeting
construct, which in these experiments was not linearized. After 8–10 days of
selection, cells were trypsinized, collected by centrifugation, ﬁxed by re-
suspending in 1 ml of 1% paraformaldehyde in PBS, incubated for 15 min and
mixed with an equal volume of 0.2% Triton X100 solution in PBS to enhance the
separation between GFP+ and GFP- peaks. FACS analysis was performed using
BD LSR Fortessa instrument. Pim1 gene targeting assay32 was performed using the
DR-GFP reporter construct which carries a hygromycin resistance gene that can
be expressed from the Pim1 promoter upon targeted integration and a puromycin
resistance gene that is under PGK promoter and is expressed after both targeted
and random integration. After electroporation cells were divided into two dishes:
10% for puromycin selection (random and targeted integration) and 90% for
hygromycin selection (targeted integration). An aliquot was taken to estimate
plating efﬁciency without selection. After 8–10 days of selection colonies were
stained and counted. The ratio of hygromycin-resistant to puromycin-resistant
colonies was interpreted as relative gene targeting efﬁciency, while the number of
hygromycin-resistant colonies per viable plated cell was deﬁned as absolute tar-
geting frequency.
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Fig. 3 Highly efﬁcient gene targeting in the absence of Pol θ. a Map of the Rad54 locus showing regions of homology with the gene targeting constructs
used in the study. The oval on the construct map indicates the location of the cassette containing the downstream part of the Rad54 CDS fused to GFP, and
a selection cassette. b FACS frequency histograms from the Rad54-GFP gene targeting assay in unirradiated and irradiated (200mGy) cells. Marker used
to determine the percentage of Rad54-GFP-positive cells is shown. As the shoulders of RI and GT peaks overlap, the number of events within the marker
under-reports or over-reports the true fraction of targeted cells, when the distribution is strongly skewed toward GT or RI, respectively. c Gene targeting
efﬁciency at the Pim1 locus (means and s.e.m. are plotted). d Gene targeting efﬁciency of exon 9 and exon 18 Rad54-GFP knock-in constructs in wild type
(ﬁlled histograms) and Polq−/− (red outline) cells
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Random integration assay. Fifteen million cells were electroporated (118 V, 1200
µF, ∞ Ω, exponential decay, GenePulser Xcell apparatus (BioRad), 2 mm cuvette
(BTX)) with 15 µg linearized (DraI digestion, followed by phenol extraction and
ethanol precipitation) or circular pLPL plasmid containing puromycin N-
acetyltransferase under mouse PGK promotor and 15 µl of circular GFP reporter
plasmid (pEGFP-N1). For mutant cell lines electroporations were done in dupli-
cates or triplicates to compensate for low plating efﬁciency. Cells were re-
suspended in 5.5 ml media and seeded at 1/5 and 4/5 dilution into 10 cm dishes;
2–4 µl samples of the 1/5 dish were plated in triplicates for plating efﬁciency
estimation; the remainder of the suspension was seeded into a 24-well plate and
analyzed by FACS the following day to estimate transfection efﬁciency. Puromycin
selection (1.5 µg/ml) was started the following day and maintained for 8–10 days.
Colonies were stained (0.25% Coomassie Brilliant Blue R (CBB), 40% methanol,
10% acetic acid), photographed and counted manually using FIJI CellCounter
plugin or with OpenCFU43.
Mapping integration sites. Insertion junctions were ampliﬁed and analyzed as
described previously44. Brieﬂy, cells were transfected with linear pLPL plasmid PCR-
products using Lipofectamine 2000 (Invitrogen). Puromycin (1.5 µg/ml) was added
24 h after transfection and colonies were allowed to grow for 8–10 days. Individual
puromycin-resistant clones were isolated and grown on 96-wells plates. At con-
ﬂuency, DNA was isolated from individual wells and plasmid-genome junctions were
ampliﬁed via TAIL-PCR45. Sequences of plasmid-speciﬁc and arbitrary degenerate
(AD) oligonucleotides used for TAIL-PCR can be found in Supplementary Data 4.
Sanger sequencing was performed using the innermost TAIL-PCR oligonucleotide
(pLPL_For-3). Subsequent automated analysis was performed by custom scripts.
High-quality DNA stretches (base error quality <0.1, stretch ≥50 nucleotides) were
identiﬁed within each Sanger sequence and further analyzed. Blast against the mouse
genome and the pLPL plasmid PCR-product was performed to identify junctions. For
each junction, the type of junction was determined (plasmid product–plasmid pro-
duct or plasmid product–mouse genome) and whether overlap existed between the
two top BLAST hits. If the two top BLAST hits overlapped it indicated the use of
(micro)homology. When no overlap between the two top BLAST hits was found, the
junction was annotated as a ﬁller. When ﬁllers were large enough (≥5 nucleotides) the
origin of the ﬁller was searched for in the pLPL plasmid and in the mouse genome at
the location the junction mapped. Total of 100 base pairs at both sides of the mapped
location were searched in normal and reverse complement orientation using the
longest common substring approach44.
Data Availability. All data generated or analyzed during this study is included in
this published article and its supplementary information.
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